Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sook Keng Yeoh

Sook Keng Yeoh is recorded as CEO at BioNexus Gene Lab Corp (BGLC). BioNexus Gene Lab Corp reported in an 8-K filed October 11, 2023 that Sook Keng Yeoh resigned as Director, effective October 4, 2023. BioNexus Gene Lab Corp reported in an 8-K filed October 11, 2023 that Sook Keng Yeoh resigned as Chief Executive Officer, effective October 4, 2023. BioNexus Gene Lab Corp reported in an 8-K filed August 15, 2022 that Sook Keng Yeoh was appointed Chief Executive Officer and director, effective August 9, 2022.

“On October 4, 2023, Mr. Sook Keng Yeoh, the Chief Executive Officer and a member of the Board of Directors, tendered his resignation letter to Bionexus Gene Lab Corp. (the "Company") from his positions at the Company. The Company and Mr. Sook Keng Yeoh agreed that the resignations would be effective October 4, 2023.”
BioNexus Gene Lab Corp Form 8-K, filed October 11, 2023 · Read the filing
“On October 4, 2023, Mr. Sook Keng Yeoh, the Chief Executive Officer and a member of the Board of Directors, tendered his resignation letter to Bionexus Gene Lab Corp. (the "Company") from his positions at the Company. The Company and Mr. Sook Keng Yeoh agreed that the resignations would be effective October 4, 2023.”
BioNexus Gene Lab Corp Form 8-K, filed October 11, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at BioNexus Gene Lab Corp

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.